神经营养素作为潜在的基因治疗对亨廷顿病的目标
Sagor Kumar Roy1, Ashima Barman2, Kumary Labone Sarkar3
1Department of Neurology, TMSS Medical College and RC Hospital, Bogura-5800, Rajshahi, Bangladesh.
Current gene therapy
|February 12, 2025
概括
神经损伤因子通过保护神经元来治疗亨廷顿病 (HD) 是有前途的. 需要进一步的基因疗法研究才能有效治疗HD.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 亨廷顿病 (HD) 是一种遗传性神经退行性疾病,影响着条状神经元和皮层神经元.
- 目前对HD病变的理解尚不完整,缺乏治愈治疗方法.
研究的目的:
- 审查亨廷顿病中神经营养因子的潜在治疗益处.
- 探索基因疗法策略,利用神经营养因子来治疗疾病.
主要方法:
- 在PubMed,Web of Science,Embase和Google Scholar的系统文献搜索.
- 对研究神经变因子和基因疗法的疗效在HD模型和患者的研究进行了审查.
主要成果:
- 使用神经变因子的基因治疗在预防神经元细胞死亡和神经退行方面表现出有希望的结果.
- 这些方法可以促进轴突和树突的生长,潜在地改善HD症状.
结论:
- 神经损伤因子是亨廷顿病神经保护疗法的潜在候选者.
- 对基因治疗的持续研究对于开发改进的HD治疗选择至关重要.
相关概念视频
Gene Therapy
25.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.1K
Enzyme-linked Receptors
77.1K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.1K


